Actym Therapeutics, Inc.

Biotechnology company · Berkeley, California, United States

Actym Therapeutics, Inc. is a biotechnology company headquartered in Berkeley, California, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Actym Therapeutics at a glance

Typebiotechnology company

HeadquartersBerkeley, California, United States

Earliest incorporation on record2017

SEC CIK1808722

What does Actym Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $11.2 million sold (2023).

Frequently asked questions about Actym Therapeutics

Where is Actym Therapeutics headquartered?

Actym Therapeutics, Inc. is headquartered in Berkeley, California, United States.

What does Actym Therapeutics do?

Actym Therapeutics, Inc. is a biotechnology company.

When was Actym Therapeutics founded?

The earliest incorporation on record for Actym Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Caribou Biosciences, Inc.Berkeley, California, United States
Newomics Inc.Berkeley, California, United States
Correlia Biosystems, Inc.Berkeley, California, United States
Synvivia, Inc.Berkeley, California, United States
Yourchoice Therapeutics IncBerkeley, California, United States
Valitor, Inc.Berkeley, California, United States
Organos, Inc.Berkeley, California, United States
Indee. Inc.Berkeley, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences